Fidelity Global Investme...【FCIG】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
ETF
カナダ
TSX
Fidelity Global Investment Grade Bond ETF (FCIG) 銘柄情報

Fidelity Global Investment Grade Bond ETF (FCIG)

21.50

0.00

(0.00%)

終了 11月25日 6:12AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

21.50

買値

21.43

売値

21.50

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

21.50

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

3,400,000

配当利回り

-

PER

-140.61

1 株当たり利益 (EPS)

-0.15

歳入

-15k

純利益

-520k

セクター

Finance Services

業界

Finance Services

本社

Toronto, Ontario, Can

設立

-

Fidelity Global Investment Grade Bond ETF is listed in the Finance Services sector of the トロント証券取引所 with ticker FCIG. The last closing price for Fidelity Global Investme... was $21.50. Over the last year, Fidelity Global Investme... shares have traded in a share price range of $ 0.00 to $ 0.00.

Fidelity Global Investme... currently has 3,400,000 shares in issue. The market capitalisation of Fidelity Global Investme... is $73.10 million. Fidelity Global Investme... has a price to earnings ratio (PE ratio) of -140.61.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.41M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.36M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	95.06M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	415.87M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	229.93M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	155.43M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	154.17M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	103.6M

Ecomike

Ecomike 1分前

100% yes. In fact it already trades.

Jack_of_All_Trades

Jack_of_All_Trades 2分前

Looking forward to a phenomenal week...

RDAR

MomsSpaghetti

MomsSpaghetti 2分前

Good listen... let's remind our self's of one thing... because the episode title is garbage.

While lysergic acid diethylamide (LSD) itself is not patentable due to its long-standing existence, MindMed has developed MM-120, a proprietary, pharmaceutically optimized form of LSD. To prot

WALL STREET KID

WALL STREET KID 2分前

http://youtube.com/post/UgkxZRwjVnRAQWfsd8xnk3jHzFq_fUZwvxOa?si=6hHQ0OcqkiMOjbQQ

wiredawg

wiredawg 2分前

Yep, I can't believe still holding this POS. SMDH!!!

Mulch_Madness

Mulch_Madness 2分前

Investing in green sustainability has become a top priority for many individuals and organizations, reflecting a growing awareness of environmental issues. People are increasingly seeking to align their financial portfolios with their values, opting for investments that not only yield financial retu

MomsSpaghetti

MomsSpaghetti 2分前

Oh this is going to be a good one for sure. :)

Jack_of_All_Trades

Jack_of_All_Trades 2分前

RDAR next epic merger play!!!

MomsSpaghetti

MomsSpaghetti 3分前

Latest episode of Motley Fool Money 💰

Check out "You Can’t Patent LSD" from Motley Fool Money on Amazon Music.

https://music.amazon.com/podcasts/2ef73bc0-7ec7-401e-bd72-23493c4933e4/episodes/ad435aee-7447-4b55-82f1-b73178ef9644/MOTLEY-FOOL-MONEYYOU-CANT-PATENT-L

Jack_of_All_Trades

Jack_of_All_Trades 3分前

RDAR next epic merger play!!!

OMOLIVES

OMOLIVES 4分前

Again...just another opinionated advertisement . You do realize that a human being didn't even write that. I hope you do......

biotechinvestor1

biotechinvestor1 5分前

Continuing with your line of thinking, (as you say pipe dreaming), it would be a bidding war between Merck and Bristol Myeres.

stealofadeal

stealofadeal 6分前

$MGON This company has a history of being sued for fraud so be very careful. This is overpriced in my opinion.

misterfishman

misterfishman 6分前

My whole life is madness so I look foward to Monday madness.

OMOLIVES

OMOLIVES 7分前

lol...... blah...blah...blah.

Ecomike

Ecomike 7分前

Yep, now that the MM Market manipulators have had time to load the boats with cheap shares, they will let loose the Banksters to print money with news shares....

https://youtu.be/9ehv29xqPP4?si=l2b6dXJxu3KxtKFx

biotechinvestor1

biotechinvestor1 7分前

style="font-family: ".SFUI-Regular"; vertical-align: 1.5px"

Mojocash

Mojocash 8分前

I agree actually. A flat tax with no loop holes would be the best. I have no problem with the corporations paying more. After 1980 Reagan screwed up the tax system, we never went back no matter who was President. Too bad Carter had bad foreign policy. His domestic policy was sweet for the people.

biotechinvestor1

biotechinvestor1 8分前

If that were the case, Halo would not have introduced the MDASE portfolio. MDASE allows competition to come to market as long as they pay license fee. It makes good Business sense.

If it was at you say and he, I wanted to stop competition in their tracks, they would not have introduce

delerious1

delerious1 9分前

But I thought there were a whole lot of reasons to get out of NBRI....glad I haven't listened

weedtrader420

weedtrader420 9分前

ELON said XRP D.O.G.E 2PAC-2 OF AMERIKAZ MOST WANTED $2.05 10 DAY TARGET

ErnieBilco

ErnieBilco 13分前

Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It
Nov. 24, 2024 6:36 AM ETArdelyx, Inc. (ARDX) Stock14 Comments
Avisol Capital Partners profile picture
Avisol Capital Partners
Investing Group Leader

Play
(8min)
Summary
A

tulla236a

tulla236a 14分前

so assparino is bashing yellen now saying the markets might crash because of her incompetence. why are they just now figuring this out?

https://nypost.com/2024/11/23/business/janet-yellen-exiting-office-leaving-mess-behind-for-trump-team/

Fidelity Global Investme...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約